Latent class analysis of chest CT abnormalities to define subphenotypes in patients with MPO-ANCA-positive

Yu Gu1, Ting Zhang1, Min Peng1

  • 1Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, No. 1 Shuai Fu Yuan Street, Dongcheng-Qu, Beijing, 100730, China.

Respiratory Medicine
|March 28, 2024
PubMed
Abstract

Insights

This study identified four distinct chest CT subphenotypes in myeloperoxidase antineutrophil cytoplasmic antibody-positive microscopic polyangiitis (MPO-MPA). Bronchiectasis emerged as a unique pattern, suggesting tailored screening and management for MPO-MPA patients.

Area of Science:

  • Pulmonary Medicine
  • Radiology
  • Immunology

Background:

  • Microscopic polyangiitis (MPA) with positive myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) presents with diverse chest CT abnormalities.
  • Identifying distinct imaging subphenotypes is crucial for understanding disease heterogeneity in MPO-ANCA-positive MPA (MPO-MPA).

Purpose of the Study:

  • To identify chest CT subphenotypes in MPO-MPA using latent class analysis (LCA).
  • To explore the relationship between these subphenotypes and clinical patterns.
  • To compare clinical characteristics and outcomes across identified MPO-MPA subphenotypes.

Main Methods:

  • Latent class analysis (LCA) was employed to categorize chest CT findings.
  • The study included 178 patients with MPO-MPA and pulmonary involvement.
  • Data were collected between June 2014 and August 2022.

Main Results:

  • Four distinct subphenotypes were identified: inflammatory exudation (Class 1), fibrosis/architectural distortion (Class 2), bronchiectasis (Class 3), and mixed inflammation/fibrosis (Class 4).
  • Class 1 showed high extrapulmonary activity and diffuse alveolar hemorrhage; Class 2 exhibited usual interstitial pneumonia and low extrapulmonary activity.
  • Class 3, characterized by bronchiectasis, had ENT complications, pre-treatment infections, and the best outcomes; Class 4 had intermediate characteristics.

Conclusions:

  • Bronchiectasis represents a unique pulmonary involvement pattern in MPO-MPA.
  • Screening for bronchiectasis in MPO-MPA is important.
  • Optimal management strategies should be identified for these distinct MPO-MPA subphenotypes.